Scientific publications
2005
Pursaethosides
A-E, triterpene saponins from Entada pursaetha
A.L.
Tapondjou, T. Miyamoto, J-F. Mirjolet, N. Guilbaud and M.A.
Lacaille-Dubois
J. Nat. Prod., 2005 Aug 26, 68(8): 1185-1190
A
virus-directed enzyme prodrug therapy (VDEPT) strategy for lung
cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein
M. Tychopoulos, L. Corcos, P. Genne, P. Beaune and I. de Waziers
Cancer Gene Ther., 2005 May, 12(5): 497-508
Tumor
penetration of gefitinib (Iressa), an epidermal growth factor
receptor tyrosine kinase inhibitor
D. McKillop, E.A. Partridge,
J.V. Kemp, M.P. Spence, J. Kendrew, S. Barnett, P.G. Wood, P.B. Giles,
A.B. Patterson, F. Bichat, N. Guilbaud and T.C. Stephens
Mol.
Cancer Ther., 2005 Apr, 4(4): 641-9
Activation
of GPR54 promotes cell cycle arrest and apoptosis of human tumor
cells through a specific transcriptional program not shared by other
Gq-coupled receptors
J.A. Becker, J.F. Mirjolet, J. Bernard, E. Burgeon, M.J. Simons, G. Vassart, M. Parmentier and F. Libert
Biochem.
Biophys. Res. Commun., 2005 Jan 21, 326(3): 677-86
Role
of non invasive animal imaging in preclinical anticancer drug
development (French review)
N. Guilbaud, O. Duchamp, N. Just and P. Genne
Bulletin
du Cancer, 2005, 92(1): 45-57
2003
Characterization
of human Smg5/7a: a protein with similarities to Caenorhabditis
elegans SMG5 and SMG7 that functions in the dephosphorylation of
Upf1
S.Y. Chiu,
G. Serin, O. Ohara and L.E. Maquat
RNA, 2003 Jan, 9(1): 77-87
Rationale supporting the use of vasoconstrictors for intraperitoneal
chemotherapy with platinum derivatives (Review)
B. Chauffert, P.
Favoulet, E. Polycarpe, C. Duvillard, J.L. Beltramo, F. Bichat, P.
Rat, P. Genne and L. Benoit
Surg. Oncol. Clin. N. Am., 2003 Jul, 12(3):
835-48
Oncoprotein
expression of E6 and E7 does not prevent 5-fluorouracil (5FU)
mediated G1/S arrest and apoptosis in 5FU resistant carcinoma cell
lines
C. Didelot,
J.F. Mirjolet, M. Barberi-Heyob, C. Ramacci, M.H. Teiten and J.L.
Merlin
Int. J. Oncol., 2003 Jul, 23(1): 81-7
Specific
recruitment of antigen-presenting cells by chemerin, a novel
processed ligand from human inflammatory fluids
V. Wittamer,
J.D. Franssen, M. Vulcano, J.F. Mirjolet, E. Le Poul, I.
Migeotte, S. Brezillon, R. Tyldesley, C. Blanpain, M. Detheux, A.
Mantovani, S. Sozzani, G. Vassart, M. Parmentier and D. Communi
J. Exp. Med., 2003 Oct 6, 198(7): 977-85
2002
Europium-labeled
epidermal growth factor and neurotensin: novel probes for
receptor-binding studies
O. Mazor, M. Hillairet de Boisferon,
A. Lombet, A. Gruaz-Guyon, B. Gayer, D. Skrzydelsky, F. Kohen, P.
Forgez, A. Scherz, W. Rostène and Y. Salomon
Analytical
Biochemistry, 2002 Feb 1, 301(1): 75-81
G(1)/S
but not G(0)/G(1)cell fraction is related to 5-fluorouracil
cytotoxicity
J.F. Mirjolet,
C. Didelot, M. Barberi-Heyob and J.L. Merlin
Cytometry, 2002 May 1, 48(1): 6-13
Improved
tumor selectivity of radiolabeled peptides by receptor and antigen
dual targeting in the neurotensin receptor model
M.
Hillairet de Boisferon., O. Raguin, C. Thiercelin, M. Dussaillant, W.
Rostène, J. Barbet, A. Pélegrin and A. Gruaz-Guyon
Bioconjug. Chem., 2002 May-Jun, 13(3): 654-62
Radiation
could induce p53-independent and cell cycle-unrelated apoptosis in
5-fluorouracil radiosensitized head and neck carcinoma cells
C. Didelot,
J.F. Mirjolet, M. Barberi-Heyob, C. Ramacci and J.L. Merlin
Canadian Journal of Physiological Pharmacology, 2002 Jul, 80(7): 638-43
Antitumor
activity of troxacitabine (Troxatyl) against anthracycline-resistant
human xenografts
H. Gourdeau, P. Genne, S. Kadhim, L. Bibeau, O. Duchamp, F. Ouellet, J.M. deMuys, D.Y. Bouffard and G. Attardo
Cancer Chemotherapy Pharmacology, 2002 Dec, 50(6): 490-6
|
Home
Back
Top